These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 19862687)

  • 1. In vivo evaluation of N-[18F]fluoroethylpiperidin-4ylmethyl acetate in rats compared with MP4A as a probe for measuring cerebral acetylcholinesterase activity.
    Kikuchi T; Okamura T; Zhang MR; Fukushi K; Irie T
    Synapse; 2010 Mar; 64(3):209-15. PubMed ID: 19862687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-[18F] fluoroethylpiperidin-4ylmethyl acetate, a novel lipophilic acetylcholine analogue for PET measurement of brain acetylcholinesterase activity.
    Kikuchi T; Zhang MR; Ikota N; Fukushi K; Okamura T; Suzuki K; Arano Y; Irie T
    J Med Chem; 2005 Apr; 48(7):2577-83. PubMed ID: 15801847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic analysis of [(11)C]MP4A using a high-radioactivity brain region that represents an integrated input function for measurement of cerebral acetylcholinesterase activity without arterial blood sampling.
    Nagatsuka Si S; Fukushi K; Shinotoh H; Namba H; Iyo M; Tanaka N; Aotsuka A; Ota T; Tanada S; Irie T
    J Cereb Blood Flow Metab; 2001 Nov; 21(11):1354-66. PubMed ID: 11702050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain acetylcholinesterase activity: validation of a PET tracer in a rat model of Alzheimer's disease.
    Irie T; Fukushi K; Namba H; Iyo M; Tamagami H; Nagatsuka S; Ikota N
    J Nucl Med; 1996 Apr; 37(4):649-55. PubMed ID: 8691261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of radiolabeled metabolite elimination from the brain on the accuracy of cerebral enzyme activity estimation using positron emission tomography with substrate tracers.
    Ohya T; Okamura T; Nagai Y; Fukushi K; Irie T; Suhara T; Zhang MR; Fukumura T; Kikuchi T
    Neuroimage; 2011 Jun; 56(3):1105-10. PubMed ID: 21324368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dementia with Lewy bodies can be well-differentiated from Alzheimer's disease by measurement of brain acetylcholinesterase activity-a [11C]MP4A PET study.
    Shimada H; Hirano S; Sinotoh H; Ota T; Tanaka N; Sato K; Yamada M; Fukushi K; Irie T; Zhang MR; Higuchi M; Kuwabara S; Suhara T
    Int J Geriatr Psychiatry; 2015 Nov; 30(11):1105-13. PubMed ID: 26280153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-[18F]fluoroethyl-4-piperidyl acetate ([18F]FEtP4A): A PET tracer for imaging brain acetylcholinesterase in vivo.
    Zhang MR; Furutsuka K; Maeda J; Kikuchi T; Kida T; Okauchi T; Irie T; Suzuki K
    Bioorg Med Chem; 2003 Jun; 11(12):2519-27. PubMed ID: 12757720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positron emission tomographic measurement of brain acetylcholinesterase activity using N-[(11)C]methylpiperidin-4-yl acetate without arterial blood sampling: methodology of shape analysis and its diagnostic power for Alzheimer's disease.
    Tanaka N; Fukushi K; Shinotoh H; Nagatsuka S; Namba H; Iyo M; Aotsuka A; Ota T; Tanada S; Irie T
    J Cereb Blood Flow Metab; 2001 Mar; 21(3):295-306. PubMed ID: 11295884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spatial distributions of cholinergic impairment and neuronal hypometabolism differ in MCI due to AD.
    Richter N; Nellessen N; Dronse J; Dillen K; Jacobs HIL; Langen KJ; Dietlein M; Kracht L; Neumaier B; Fink GR; Kukolja J; Onur OA
    Neuroimage Clin; 2019; 24():101978. PubMed ID: 31422337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET probes for imaging brain acetylcholinesterase.
    Kikuchi T; Okamura T; Zhang MR; Irie T
    J Labelled Comp Radiopharm; 2013; 56(3-4):172-9. PubMed ID: 24285323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of plasma IC50 of donepezil hydrochloride for brain acetylcholinesterase inhibition in monkey using N-[11C]methylpiperidin-4-yl acetate ([11C]MP4A) and PET.
    Shiraishi T; Kikuchi T; Fukushi K; Shinotoh H; Nagatsuka S; Tanaka N; Ota T; Sato K; Hirano S; Tanada S; Iyo M; Irie T
    Neuropsychopharmacology; 2005 Dec; 30(12):2154-61. PubMed ID: 15920507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral acetylcholinesterase imaging: development of the radioprobes.
    Kikuchi T; Okamura T; Fukushi K; Takahashi K; Toyohara J; Okada M; Zhang MR; Irie T
    Curr Top Med Chem; 2007; 7(18):1790-9. PubMed ID: 17979787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human cerebral acetylcholinesterase activity measured with positron emission tomography: procedure, normal values and effect of age.
    Namba H; Iyo M; Fukushi K; Shinotoh H; Nagatsuka S; Suhara T; Sudo Y; Suzuki K; Irie T
    Eur J Nucl Med; 1999 Feb; 26(2):135-43. PubMed ID: 9933347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and preliminary evaluation of [18F]FEtP4A, a promising PET tracer for mapping acetylcholinesterase in vivo.
    Zhang MR; Tsuchiyama A; Haradahira T; Furutsuka K; Yoshida Y; Kida T; Noguchi J; Irie T; Suzuki K
    Nucl Med Biol; 2002 May; 29(4):463-8. PubMed ID: 12031881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simple method for the detection of abnormal brain regions in Alzheimer's disease patients using [11C]MP4A: comparison with [123I]IMP SPECT.
    Ota T; Shinotoh H; Fukushi K; Nagatsuka S; Namba H; Iyo M; Aotsuka A; Tanaka N; Sato K; Shiraishi T; Tanada S; Arai H; Irie T
    Ann Nucl Med; 2004 May; 18(3):187-93. PubMed ID: 15233279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The integrity of the cholinergic system determines memory performance in healthy elderly.
    Richter N; Allendorf I; Onur OA; Kracht L; Dietlein M; Tittgemeyer M; Neumaier B; Fink GR; Kukolja J
    Neuroimage; 2014 Oct; 100():481-8. PubMed ID: 24952230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A method to predict the ratio of the tracer conversion rate to the tracer back-diffusion rate of an irreversible-type radiotracer in humans by preclinical evaluations.
    Ohya T; Zhang MR; Fukumura T; Fukushi K; Kikuchi T; Irie T
    Nucl Med Commun; 2012 Oct; 33(10):1019-23. PubMed ID: 22850605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of 18F-labeled acetylcholinesterase substrates as PET radiotracers.
    Shao X; Koeppe RA; Butch ER; Kilbourn MR; Snyder SE
    Bioorg Med Chem; 2005 Feb; 13(3):869-75. PubMed ID: 15653352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vivo measurements of regional acetylcholine esterase activity in degenerative dementia: comparison with blood flow and glucose metabolism.
    Herholz K; Bauer B; Wienhard K; Kracht L; Mielke R; Lenz MO; Strotmann T; Heiss WD
    J Neural Transm (Vienna); 2000; 107(12):1457-68. PubMed ID: 11458998
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.